Shanghai Research Development vs Total Operating Expenses Analysis

688085 Stock

22.70 0.42 1.82%

Shanghai Sanyou financial indicator trend analysis is much more than just breaking down Shanghai Sanyou Medical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Shanghai Sanyou Medical is a good investment. Please check the relationship between Shanghai Sanyou Research Development and its Total Operating Expenses accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shanghai Sanyou Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Research Development vs Total Operating Expenses

Research Development vs Total Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Shanghai Sanyou Medical Research Development account and Total Operating Expenses. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Shanghai Sanyou's Research Development and Total Operating Expenses is 0.93. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Shanghai Sanyou Medical, assuming nothing else is changed. The correlation between historical values of Shanghai Sanyou's Research Development and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Shanghai Sanyou Medical are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Research Development i.e., Shanghai Sanyou's Research Development and Total Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.93

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most indicators from Shanghai Sanyou's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Shanghai Sanyou Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shanghai Sanyou Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 190.5 M, whereas Tax Provision is forecasted to decline to about 17.6 M.

	2021	2022	2023	2024 (projected)
Gross Profit	537.0M	585.4M	368.1M	348.1M
Total Revenue	593.4M	649.2M	460.4M	396.7M

Gross Profit Total Revenue

Shanghai Sanyou fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Total Current Assets	Non Current Liabilities Other	Intangible Assets	Other Current Liab	Other Liab	Net Tangible Assets	Other Assets	Common Stock Shares Outstanding	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Common Stock	Property Plant Equipment
Total Assets		0.96	1.0	0.93	0.65	0.83	0.86	0.72	0.75	0.95	0.97	-0.1	0.96	0.93	0.6	0.79	0.58	0.88	0.99	0.97	0.97	0.98	1.0	0.87	0.96	0.89
Total Current Liabilities	0.96		0.95	0.92	0.6	0.77	0.86	0.69	0.83	0.97	0.93	0.03	1.0	0.86	0.7	0.72	0.7	0.86	0.91	0.96	0.89	0.95	0.94	0.77	0.87	0.88
Total Stockholder Equity	1.0	0.95		0.92	0.65	0.83	0.85	0.7	0.74	0.94	0.96	-0.13	0.95	0.94	0.6	0.79	0.57	0.87	0.99	0.96	0.97	0.97	1.0	0.89	0.96	0.88
Retained Earnings	0.93	0.92	0.92		0.77	0.94	0.98	0.88	0.62	0.92	0.94	0.03	0.92	0.81	0.42	0.92	0.42	0.99	0.9	0.93	0.95	0.94	0.93	0.75	0.92	0.99
Accounts Payable	0.65	0.6	0.65	0.77		0.8	0.73	0.69	0.34	0.51	0.67	0.16	0.59	0.63	-0.01	0.83	-0.08	0.76	0.67	0.69	0.72	0.74	0.65	0.59	0.7	0.81
Cash	0.83	0.77	0.83	0.94	0.8		0.95	0.85	0.34	0.77	0.85	-0.05	0.77	0.72	0.14	0.99	0.16	0.96	0.82	0.82	0.92	0.83	0.85	0.7	0.89	0.95
Non Current Assets Total	0.86	0.86	0.85	0.98	0.73	0.95		0.92	0.49	0.88	0.91	0.05	0.87	0.69	0.3	0.95	0.34	0.99	0.81	0.89	0.91	0.87	0.87	0.61	0.88	0.99
Non Currrent Assets Other	0.72	0.69	0.7	0.88	0.69	0.85	0.92		0.31	0.76	0.82	0.12	0.7	0.51	0.11	0.89	0.13	0.91	0.68	0.77	0.83	0.75	0.73	0.45	0.8	0.9
Net Receivables	0.75	0.83	0.74	0.62	0.34	0.34	0.49	0.31		0.77	0.63	-0.03	0.83	0.78	0.93	0.29	0.86	0.5	0.7	0.71	0.56	0.72	0.71	0.69	0.54	0.55
Non Current Liabilities Total	0.95	0.97	0.94	0.92	0.51	0.77	0.88	0.76	0.77		0.94	-0.04	0.98	0.81	0.67	0.73	0.69	0.88	0.9	0.95	0.9	0.93	0.94	0.72	0.89	0.88
Inventory	0.97	0.93	0.96	0.94	0.67	0.85	0.91	0.82	0.63	0.94		0.06	0.94	0.81	0.46	0.84	0.47	0.91	0.94	0.99	0.97	0.98	0.96	0.73	0.98	0.92
Other Current Assets	-0.1	0.03	-0.13	0.03	0.16	-0.05	0.05	0.12	-0.03	-0.04	0.06		0.02	-0.24	-0.13	-0.01	-0.05	0.0	-0.13	0.11	-0.09	0.08	-0.11	-0.3	-0.08	0.08
Total Liab	0.96	1.0	0.95	0.92	0.59	0.77	0.87	0.7	0.83	0.98	0.94	0.02		0.86	0.7	0.73	0.7	0.87	0.91	0.96	0.89	0.95	0.95	0.77	0.88	0.88
Total Current Assets	0.93	0.86	0.94	0.81	0.63	0.72	0.69	0.51	0.78	0.81	0.81	-0.24	0.86		0.64	0.66	0.57	0.73	0.95	0.83	0.86	0.87	0.94	0.98	0.84	0.75
Non Current Liabilities Other	0.6	0.7	0.6	0.42	-0.01	0.14	0.3	0.11	0.93	0.67	0.46	-0.13	0.7	0.64		0.06	0.97	0.3	0.54	0.53	0.39	0.52	0.57	0.57	0.38	0.33
Intangible Assets	0.79	0.72	0.79	0.92	0.83	0.99	0.95	0.89	0.29	0.73	0.84	-0.01	0.73	0.66	0.06		0.08	0.96	0.78	0.8	0.9	0.81	0.81	0.63	0.87	0.95
Other Current Liab	0.58	0.7	0.57	0.42	-0.08	0.16	0.34	0.13	0.86	0.69	0.47	-0.05	0.7	0.57	0.97	0.08		0.32	0.51	0.53	0.38	0.5	0.55	0.5	0.37	0.33
Other Liab	0.88	0.86	0.87	0.99	0.76	0.96	0.99	0.91	0.5	0.88	0.91	0.0	0.87	0.73	0.3	0.96	0.32		0.84	0.89	0.93	0.89	0.89	0.67	0.9	0.99
Net Tangible Assets	0.99	0.91	0.99	0.9	0.67	0.82	0.81	0.68	0.7	0.9	0.94	-0.13	0.91	0.95	0.54	0.78	0.51	0.84		0.94	0.97	0.96	0.99	0.92	0.96	0.85
Other Assets	0.97	0.96	0.96	0.93	0.69	0.82	0.89	0.77	0.71	0.95	0.99	0.11	0.96	0.83	0.53	0.8	0.53	0.89	0.94		0.94	0.99	0.95	0.74	0.95	0.91
Common Stock Shares Outstanding	0.97	0.89	0.97	0.95	0.72	0.92	0.91	0.83	0.56	0.9	0.97	-0.09	0.89	0.86	0.39	0.9	0.38	0.93	0.97	0.94		0.95	0.98	0.82	0.99	0.93
Deferred Long Term Liab	0.98	0.95	0.97	0.94	0.74	0.83	0.87	0.75	0.72	0.93	0.98	0.08	0.95	0.87	0.52	0.81	0.5	0.89	0.96	0.99	0.95		0.96	0.8	0.95	0.92
Net Invested Capital	1.0	0.94	1.0	0.93	0.65	0.85	0.87	0.73	0.71	0.94	0.96	-0.11	0.95	0.94	0.57	0.81	0.55	0.89	0.99	0.95	0.98	0.96		0.89	0.97	0.89
Net Working Capital	0.87	0.77	0.89	0.75	0.59	0.7	0.61	0.45	0.69	0.72	0.73	-0.3	0.77	0.98	0.57	0.63	0.5	0.67	0.92	0.74	0.82	0.8	0.89		0.8	0.68
Common Stock	0.96	0.87	0.96	0.92	0.7	0.89	0.88	0.8	0.54	0.89	0.98	-0.08	0.88	0.84	0.38	0.87	0.37	0.9	0.96	0.95	0.99	0.95	0.97	0.8		0.9
Property Plant Equipment	0.89	0.88	0.88	0.99	0.81	0.95	0.99	0.9	0.55	0.88	0.92	0.08	0.88	0.75	0.33	0.95	0.33	0.99	0.85	0.91	0.93	0.92	0.89	0.68	0.9

Click cells to compare fundamentals

Shanghai Sanyou Account Relationship Matchups

Shanghai Sanyou fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	551.5M	1.7B	2.0B	2.2B	2.3B	1.3B
Total Current Liabilities	106.6M	123.7M	234.9M	245.0M	194.4M	138.1M
Total Stockholder Equity	437.8M	1.5B	1.7B	1.8B	1.9B	1.1B
Retained Earnings	156.9M	275.4M	425.7M	579.2M	581.5M	610.5M
Accounts Payable	67.6M	65.8M	20.3M	28.1M	100.7M	105.7M
Cash	37.5M	262.5M	382.3M	340.4M	654.4M	687.1M
Non Current Assets Total	208.8M	229.7M	846.6M	1.2B	1.3B	1.4B
Non Currrent Assets Other	8.0M	6.3M	6.9M	170.6M	158.4M	166.3M
Net Receivables	172.7M	196.4M	248.9M	275.4M	61.5M	58.4M
Non Current Liabilities Total	7.1M	12.6M	26.0M	33.3M	24.3M	16.3M
Inventory	68.2M	93.2M	121.5M	155.1M	176.7M	102.9M
Other Current Assets	64.2M	4.6M	14.9M	27.7M	28.8M	23.7M
Total Liab	113.7M	136.2M	260.9M	278.3M	218.8M	154.4M
Total Current Assets	342.6M	1.4B	1.2B	994.4M	946.3M	762.8M
Non Current Liabilities Other	5.3M	7.8M	12.6M	12.6M	719.4K	683.5K
Intangible Assets	1.5M	23.8M	32.8M	41.0M	85.6M	89.9M
Other Current Liab	27.0M	32.3M	89.5M	81.8M	616.6K	585.8K
Other Liab	7.1M	12.6M	23.5M	31.0M	35.6M	37.4M
Net Tangible Assets	414.9M	1.5B	1.3B	1.5B	1.7B	977.4M
Other Assets	36.3M	40.1M	59.9M	70.1M	80.6M	42.8M
Deferred Long Term Liab	16.2M	20.2M	22.7M	26.2M	30.1M	18.8M
Net Invested Capital	437.8M	1.5B	1.7B	1.8B	1.9B	1.3B
Net Working Capital	236.1M	1.3B	915.7M	749.4M	751.9M	694.8M
Property Plant Equipment	140.6M	155.9M	256.3M	345.4M	397.2M	417.1M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in Shanghai Stock

Balance Sheet is a snapshot of the financial position of Shanghai Sanyou Medical at a specified time, usually calculated after every quarter, six months, or one year. Shanghai Sanyou Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Shanghai Sanyou and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Shanghai currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Shanghai Research Development vs Total Operating Expenses Analysis

Research Development vs Total Operating Expenses

Research Development vs Total Operating Expenses Correlation Analysis

Correlation Coefficient

Research Development

Total Operating Expenses

Shanghai Sanyou fundamental ratios Correlations

Shanghai Sanyou Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Shanghai Sanyou fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Tangible Assets	+ 0.99	Total Assets
Net Tangible Assets	+ 0.99	Total Stockholder Equity

Net Working Capital	- 0.3	Other Current Assets
Total Current Assets	- 0.24	Other Current Assets
Net Tangible Assets	- 0.13	Other Current Assets
Non Current Liabilities Other	- 0.13	Other Current Assets
Other Current Assets	- 0.13	Total Stockholder Equity
Net Invested Capital	- 0.11	Other Current Assets